Newbridge Financial Services Group, Inc. Neu Base Therapeutics, Inc. Transaction History

Newbridge Financial Services Group, Inc.

1 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2020 Sep 07, 2021	BUY	$7.25 - $9.71 $1,812 - $2,427	250 New	250 $2,000

Ticker NBSE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,258,700
Description
NeuBase Therapeutics, Inc., a pre-clinical-stage biopharmaceutical company, focuses on the development of therapies to treat rare genetic diseases and cancers caused by mutant genes. The company's proprietary modular peptide-nucleic acid antisense oligo (PATrOL) platform focuses on addressing Huntington's disease (HD) and myotonic dystrophy, as ...

Get notified when there are updates to the investment portfolio of Newbridge Financial Services Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Newbridge Financial Services Group, Inc. with notifications on news.